Irritable bowel syndrome: How to improve decision making in clinical practice

Whitehead, 2013 Lovell, 2012, Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis, Clin Gastroenterol Hepatol, 10, 712, 10.1016/j.cgh.2012.02.029 Mearin, 2012, Diagnostic criteria in IBS: useful or not?, Neurogastroenterol Motil, 24, 791, 10.1111/j.1365-2982.2012.01992.x Lacy, 2016, Bowel disorders, Gastroenterology, 150, 1393, 10.1053/j.gastro.2016.02.031 Patel, 2015, Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey, Scand J Gastroenterol, 50, 1, 10.3109/00365521.2015.1007079 Patel, 2014, Prevalence of organic gastrointestinal disease in suspected irritable bowel syndrome varies according to subtype, United European Gastroenterol J, 2, A243 Whitehead, 2007, Comorbidity in irritable bowel syndrome, Am J Gastroenterol, 102, 2767, 10.1111/j.1572-0241.2007.01540.x Austin, 2013, An international Delphi study to assess the need for multiaxial criteria in diagnosis and management of functional gastrointestinal disorders, J Psychosom Res, 75, 128, 10.1016/j.jpsychores.2013.05.008 Di Palma, 2012, The role of effective clinical-patient communication in the management of irritable bowel syndrome and chronic constipation, J Clin Gastroenterol, 46, 748, 10.1097/MCG.0b013e31825a2ff2 Lewis, 1997, Stool form scale as a useful guide to intestinal transit time, Scand J Gastroenterol, 32, 920, 10.3109/00365529709011203 Mearin, 2016, Clinical Practice Guideline: irritable bowel syndrome with constipation and functional constipation in the adult, Rev Esp Enferm Dig, 108, 332 Rey, 2014, Chronic constipation, irritable bowel syndrome with constipation and constipation with pain/discomfort: similarities and differences, Am J Gastroenterol, 109, 876, 10.1038/ajg.2014.18 Whitehead, 2006, Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome, Aliment Pharmacol Ther, 24, 137, 10.1111/j.1365-2036.2006.02956.x Gupta, 2010, Constipation is not associated with an increased rate of findings on colonoscopy: results from a national endoscopy consortium, Endoscopy, 42, 208, 10.1055/s-0029-1243843 Irritable bowel syndrome in adults: diagnosis and management. Guidance and guidelines. NICE. Available at: https://www.nice.org.uk/guidance/cg61 [accessed 11.10.17]. Brandt, 2009, An evidence-based position statement on the management of irritable bowel syndrome, Am J Gastroenterol, 104, S1 Ford, 2009, Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis, Arch Intern Med, 169, 651, 10.1001/archinternmed.2009.22 Guagnozzi, 2016, Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders, Aliment Pharmacol Ther, 43, 851, 10.1111/apt.13573 2015, Diagnosis and management of irritable bowel syndrome in adults in primary care: summary of NICE guidance, BMJ, 350, h1216, 10.1136/bmj.h1216 Francis, 1997, The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress, Aliment Pharmacol Ther, 11, 395, 10.1046/j.1365-2036.1997.142318000.x Almansa, 2011, Traducción, adaptación cultural y validación al español del cuestionario de gravedad del síndrome de intestino irritable, Rev Esp Enferm Dig, 103, 612, 10.4321/S1130-01082011001200002 Johannesson, 2011, Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial, Am J Gastroenterol, 106, 915, 10.1038/ajg.2010.480 Mearin, 2014, Importancia de la dieta en el síndrome del intestino irritable, Gastroenterol Hepatol, 37, 302, 10.1016/j.gastrohep.2013.12.010 Ford, 2008, Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis, BMJ, 337, a2313, 10.1136/bmj.a2313 El-Salhy, 2017, Dietary fiber in irritable bowel syndrome (Review), Int J Mol Med, 40, 607, 10.3892/ijmm.2017.3072 De Roest, 2013, The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study, Int J Clin Pract, 67, 895, 10.1111/ijcp.12128 Halmos, 2014, A diet low in FODMAPs reduces symptoms of irritable bowel syndrome, Gastroenterology, 146, 10.1053/j.gastro.2013.09.046 Böhn, 2015, Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial, Gastroenterology, 149, 1399, 10.1053/j.gastro.2015.07.054 Varjú, 2017, Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: a meta-analysis of clinical studies, PLOS ONE, 12, e0182942, 10.1371/journal.pone.0182942 Carroccio, 2012, Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: Exploring a new clinical entity, Am J Gastroenterol, 107, 1898, 10.1038/ajg.2012.236 Molina-Infante, 2017, Suspected nonceliac gluten sensitivity confirmed in few patients after gluten challenge in double-blind placebo-controlled trials, Clin Gastroenterol Hepatol, 15, 339, 10.1016/j.cgh.2016.08.007 Madisch, 2004, Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial, Aliment Pharmacol Ther, 19, 271, 10.1111/j.1365-2036.2004.01859.x Poynard, 2001, Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome, Aliment Pharmacol Ther, 15, 355, 10.1046/j.1365-2036.2001.00937.x Mueller-Lissner, 2006, Placebo- and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain, Aliment Pharmacol Ther, 23, 1741, 10.1111/j.1365-2036.2006.02818.x Clavé, 2011, Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome, Aliment Pharmacol Ther, 34, 432, 10.1111/j.1365-2036.2011.04730.x Zheng, 2015, Pinaverium reduces symptoms of irritable bowel syndrome in a multicenter, randomized controlled trial, Clin Gastroenterol Hepatol, 13, 1285, 10.1016/j.cgh.2015.01.015 Camilleri, 2000, Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial, Lancet, 355, 1035, 10.1016/S0140-6736(00)02033-X Matsueda, 2008, A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome, Scand J Gastroenterol, 43, 1202, 10.1080/00365520802240255 Cha, 2012, Efficacy of ramosetron in male patients with irritable bowel syndrome with diarrhea (Neurogastroenterol Motil 2011;23:1098–1104), J Neurogastroenterol Motil, 18, 224, 10.5056/jnm.2012.18.2.224 Atluri, 2014, Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a systematic review and meta-analysis, Neurogastroenterol Motil, 26, 499, 10.1111/nmo.12292 Layer, 2014, Review article: Linaclotide for the management of irritable bowel syndrome with constipation, Aliment Pharmacol Ther, 39, 371, 10.1111/apt.12604 Lembo, 2010, Efficacy of linaclotide for patients with chronic constipation, Gastroenterology, 138, 886, 10.1053/j.gastro.2009.12.050 Johnston, 2010, Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation, Gastroenterology, 139, 1877, 10.1053/j.gastro.2010.08.041 Quigley, 2013, Randomised clinical trials: Linaclotide phase 3 studies in IBS-C—a prespecified further analysis based on European Medicines Agency-specified endpoints, Aliment Pharmacol Ther, 37, 49, 10.1111/apt.12123 Chey, 2012, Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety, Am J Gastroenterol, 107, 1702, 10.1038/ajg.2012.254 Videlock, 2013, Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis, Clin Gastroenterol Hepatol, 11, 1084, 10.1016/j.cgh.2013.04.032 Lembo, 2016, Eluxadoline for irritable bowel syndrome with diarrhea, N Engl J Med, 374, 242, 10.1056/NEJMoa1505180 Brunoni, 2008, A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression, Int J Neuropsychopharmacol, 11, 1169, 10.1017/S1461145708009309 Ford, 2009, Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis, Gut, 58, 367, 10.1136/gut.2008.163162 Tack, 2006, A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome, Gut, 55, 1095, 10.1136/gut.2005.077503 Brennan, 2009, Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study, Hum Psychopharmacol, 24, 423, 10.1002/hup.1038 Chial, 2003, Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans, Clin Gastroenterol Hepatol, 1, 211, 10.1016/S1542-3565(03)70038-X Rey, 2017, Optimizing the use of linaclotide in patients with constipation-predominant irritable bowel syndrome: an expert consensus report, Adv Ther, 34, 587, 10.1007/s12325-016-0473-8 Sajid, 2016, Use of prucalopride for chronic constipation: a systematic review and meta-analysis of published randomized controlled trials, J Neurogastroenterol Motil, 22, 412, 10.5056/jnm16004 Bajor, 2015, Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS, Gut, 64, 84, 10.1136/gutjnl-2013-305965 Efskind, 1996, A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome, Scand J Gastroenterol, 31, 463, 10.3109/00365529609006766 Pimentel, 2011, Rifaximin therapy for patients with irritable bowel syndrome without constipation, N Engl J Med, 364, 22, 10.1056/NEJMoa1004409 Mearin, 2003, Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype, Eur J Gastroenterol Hepatol, 15, 165, 10.1097/00042737-200302000-00010 Whitehead, 2017, Irritable bowel syndrome: what do the new Rome IV diagnostic guidelines mean for patient management?, Expert Rev Gastroenterol Hepatol, 11, 281, 10.1080/17474124.2017.1292130 Vahedi, 2008, Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome, Aliment Pharmacol Ther, 27, 678, 10.1111/j.1365-2036.2008.03633.x